GLP-1 receptor agonists linked to lower ascites, mortality in MASH
AJMC reports GLP-1 use associated with reduced ascites and death among patients with metabolic dysfunction-associated steatohepatitis.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 17:33 ETSource: ajmc.com
The wire
- 01Report describes GLP-1 receptor agonists cutting ascites and mortality in MASH patients.
- 02MASH complications are a major unmet need with few approved options.
- 03Study design, size and confounders are not detailed in the source.
From the source
Read at news.google.comGLP-1 Receptor Agonists Cut Ascites, Mortality in MASH